MINSK, 22 November (BelTA) – The international statement on expanding access to affordable and quality assured medicines and diagnostics will help coordinate efforts of Eastern Europe and Central Asia (EECA)…
The 2018 Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor. Amsterdam, the Netherlands, 20 November…
-- Low- and middle-income countries receive donor support for HIV and TB drugs from the Global Fund, but are gradually losing this support -- Global Fund policies on countries that…
Important collaboration will ensure affordable hepatitis C treatment options in low- and middle-income countries. San Francisco, 12 November 2018 – The Medicines Patent Pool (MPP) has today announced a new,…
Today, on the occasion of the joint meeting of the EU Civil Society Forum on HIV, Hepatitis and TB and the EU Civil Society Forum on Drugs, the European AIDS…
The European Observatory on Health Systems and Policies released two policy briefs on access to medicines: Ensuring access to medicines: How to stimulate innovation to meet patients' needs? This policy…
Calls on US pharma corporation Johnson & Johnson to cut key TB drug price in half The Hague, 23 October 2018 — People with drug-resistant tuberculosis (DR-TB) continue to be…
HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. In this issue of HTB: BHIVA and Ageing Conferences, PrEP guidelines. The bulletin can be accessed here.
Provider-centric stigma reduction interventions can help reduce stigmatizing behaviors towards patients with HIV and potentially improve care, according to a new systematic review from the CDC. Despite national progress in…
I refer to the reply by the Equality Ministry ‘LGBTIQ action plan’ (September 20) to my comments in ‘HIV treatment in Malta archaic, activist warns’. In its reply, the government…
Share the EATG site:
 |  |  |
